Academic exchange between the University of Tottori in Japan and the DRFZ

The DRFZ and the Faculty of Medicine at the University of Tottori in Japan have signed an agreement on an academic exchange program.

1 Min
More

Interview | Prof. Dr. Georg N. Duda, Director Julius Wolff Institute and Dr. Garima Bhardwaj Head of the BIH Clinical Incubator

Building a community for bringing advanced and regenerative therapies to the patients

10 Min
More

Business mission on Japanese Culture May/June 2025 - call for applications

"Get Ready for Japan" training programme

1 Min
More

PanK4 Identified as Regulator of Glucose and Lipid Metabolism

Physical activity is not only important for fitness but also for overall health. This is confirmed by a new study conducted under the leadership of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE).…

4 Min
More

New method for the analysis of intestinal bacteria

Prospects for personalized medicine in Crohn’s disease

1 Min
More

Future Tech Days @ Charité BIH Innovation - Pitching opportunity for digital health startups

The Charité BIH Innovation team established a new event series to expand the matching and connecting activities and to create a broader platform: The Future Tech Days – where digital health startups and members of Charité meet for a short pitch…

1 Min
More

Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…

1 Min
More

EIB provides €35 million to Formo to expand production of cheese alternatives free from animal products

- Berlin-based food tech company Formo develops fermentation processes to produce cheese alternatives.

- The €35 million EIB investment is backed by the European Union's InvestEU guarantee.

- This venture debt loan brings Formo’s total financing to…

4 Min
More

Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic

Model was generated in only two months and sets new industry standard for performance

3 Min
More

Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TAMUC1 Antibody in DS-3939 from Glycotope GmbH

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab.

3 Min
More
Show more items